Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by pidukson Aug 08, 2024 10:35am
79 Views
Post# 36169398

W.H.O. to declare monkeypox global emergency & cannabinonids

W.H.O. to declare monkeypox global emergency & cannabinonidsare effective against it.   

1) Monkeypox might be declared a global emergency after WHO calls emergency meeting
The World Health Organisation has called an emergency meeting in order to address an international outbreak of the deadly monkeypox virus. Since the current strain of the virus was first detected in the Democratic Republic of Congo in April, it has evolved to become even more infectious and deadly – killing up to one in 10 people who catch it. Now the virus has spread outside of the DRC, prompting the WHO to call on public health experts to advise ‘on whether the outbreak represents a public health emergency of international concern’

2) 2021 Oct-Dec; 42(4): 175.
Published online 2023 May 17

Marijauna (Cannabis sativa L.) and roles against monkeypox
Rujittika Mungmunpuntipantip1 and Viroj Wiwanitkit2,3

Re-emergence of monkeypox is a significant global public health problem. In general, monkeypox is a kind of viral infection that is in the same group as smallpox infection. When there is a cessation of routine smallpox vaccination, there is a gradual decrease in immunity and it results in the present emergence of monkeypox. Now, the disease has become a global problem and has been reported in several countries outside Africa, as the origin of the infection. It is possible to miss diagnosing the illness when it manifests as a skin lesion and fever.[1] Additionally conceivable are uncommon clinical issues including gastrointestinal issues.[1] An interesting topic for many ongoing studies, is the treatment of monkeypox. It would be interesting to conduct a study on the function of conventional herbal management. The authors want to talk about how licensed medical Marijuana (Cannabis sativa L.) can be used here to treat monkeypox. The potential role in symptomatic and supportive care, particularly for pain management, is suggested.[2] The role of cannabidiol in virus suppression is also mentioned.[2] However, there has been no concrete research on Marijuana potential to treat monkeypox. As Vallee[3] points out, cannabis and alcohol consumption may have two negative effects on the monkeypox virus (MPXV) outbreak: increasing the number of sexual partners, which is primarily responsible for the increase in the number of new MPXV-infected cases, and impairing the immune response to a viral infection. It should be noted, however, that medical Marijuana with a well-controlled therapeutic approach can be useful and is not linked to addiction.[4] Medical Marijuana potential role in the treatment of monkeypox should be investigated further. According to the literature, cannabinoids may have clinical effects through the inflammatory response as well as neuroprotective effects.[5] The fundamental pharmacological activities that are suggested as being advantageous in the therapeutic treatment of cannabis on viral infections, particularly HIV-1, are listed.[4] Additionally, whether or not they operate through a specific receptor, cannabinoids have the capacity to modulate mitochondria, which has the potential to have an impact on a variety of cell types.[4]




<< Previous
Bullboard Posts
Next >>